Synapse Medicine

Synapse Medicine

Achieving Medication Success with Clinical Decision Support

Founded 2017 France

France 84 employees Series B Total: $35.50M Health Care, Medical Devices +1

Synapse Medicine, founded in 2017, is a promising player in the Health Care sector, focusing on transforming medication management through advanced technology. Headquartered in France, the company seeks to achieve "Medication Success with Clinical Decision Support."

Their innovative approach utilizes a comprehensive global knowledge base driven by sophisticated algorithms, offering a SaaS platform designed for effective prescription and medication management throughout the patient journey. By partnering with leading hospitals and digital health companies across the United States, Europe, and Japan, Synapse aims to set new standards in medication regimens.

Synapse Medicine's growth trajectory is reinforced by a significant €25.00M Series B investment received in March 2022 from prominent investors such as XAnge, BNP Paribas Developpement, Korelya Capital, MACSF, and Mutuelles Impact. This funding supports their mission to solidify their innovation-driven position in the Medical Devices and Pharmaceutical industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	€25.00M	5	XAnge, BNP Paribas Developpement +3	01 Mar 2022
Series A	$8.00M	5	Bpifrance, XAnge +3	06 Jul 2020
Seed Round	€2.50M	1	XAnge	19 Mar 2019

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

€25.00M

XAnge, BNP Paribas Developpement +3

01 Mar 2022

Series A

$8.00M

Bpifrance, XAnge +3

06 Jul 2020

Seed Round

€2.50M

XAnge

19 Mar 2019

FAQ About Synapse Medicine

Achieving Medication Success with Clinical Decision Support

Synapse Medicine was founded in 2017.

Synapse Medicine is headquartered in France. As of Aug 2026, it also has offices in Bordeaux, France and New York, United States.

Synapse Medicine operates in Health Care, Medical Devices and Pharmaceutical. Its work centres on Medication Success, Clinical Decision Support, SaaS Platform and Digital Health. Its customers include Healthcare Providers, EHR System Developers and Telemedicine Platforms.

Synapse Medicine has a SaaS, B2B and API business model. Its revenue comes from Subscription, Licensing and Usage Based.

As listed on Synapse Medicine's pricing page on Oct 30, 2026: from €22/month per user (Aide à la Prescription: €29.99/month per user; Aide à la Dispensation: €29.99/month per user; Pharmacy: €52/month; User: €22/month per user).

Synapse Medicine has approximately 84 employees.

Synapse Medicine has completed 3 funding rounds, raising a total of $35.50M. The latest funding stage is Series B.

Synapse Medicine offers: E-prescribing Software Integration, Clinical Decision Support Components, Medication Reconciliation, Customer Success and Support.

Top alternatives and competitors to Synapse Medicine include Orikami, HealNow, CareLink (by Asepha), Echo, Hyfe. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Synapse Medicine and Orikami are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Synapse Medicine

Services & Products

Target Customers

Pricing

Funding Rounds & Investors (3)

Synapse Medicine Alternatives & Competitors

FAQ About Synapse Medicine